![](/img/cover-not-exists.png)
Reduced-dose ipilimumab with standard-dose pembrolizumab: is less more?
Postow, MichaelLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(17)30518-1
Date:
July, 2017
File:
PDF, 96 KB
english, 2017